Melatonin Delays Brain Aging by Decreasing the Nitric Oxide Level

被引:6
作者
Akbulut, K. G. [1 ]
Guney, S. [1 ]
Cetin, F. [1 ]
Akgun, H. N. [2 ]
Aktas, S. H. [2 ]
Akbulut, H. [2 ]
机构
[1] Gazi Univ, Dept Physiol, Sch Med, Ankara, Turkey
[2] Ankara Univ, Dept Med Oncol, Sch Med, TR-06100 Ankara, Turkey
关键词
aging; caspase-3; melatonin; nitric oxide; temporal cortex; frontal cortex; hippocampus; OXIDATIVE STRESS; NEURODEGENERATIVE DISORDERS; IN-VITRO; AGE; APOPTOSIS; CELLS; CASPASES; DEATH; ACTIVATION; SYNTHASE;
D O I
10.1007/s11062-013-9368-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aging is believed to be a first-order risk factor for most neurodegenerative disorders. The neuronal cell loss that occurs with aging has been partly attributed to increased production of nitric oxide and high caspase activity. Melatonin (MLT) might have a role in the regulation of nitric oxide in the brain. We investigated the effects of MLT on the nitrite/nitrate levels and caspase-3 enzyme activity in the frontal cortex, temporal cortex, and hippocampus of young and aged rats. There was no significant difference between the nitrite levels in the frontal cortex and hippocampus of young and aged animals. In the temporal cortex of aged rats, the nitrite level, however, was significantly higher (P < 0.001). In the aged group, MLT significantly decreased these levels in the brain regions. Caspase-3 enzyme activity in the temporal and frontal cortices was significantly higher in aged rats when compared to the control group (P < 0.05). Melatonin did not cause significant changes in caspase-3 activity in any brain region of both young and aged rats. Thus, brain regions demonstrate different caspase-3 enzyme activities and nitrite levels in the aging process. Exogenous MLT administration might delay brain aging (by moderation of death of neurons and glia) via decreasing the nitrite/nitrate level.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 39 条
[1]   Exogenous melatonin decreases age-induced lipid peroxidation in the brain [J].
Akbulut, K. Gonca ;
Gonul, Bilge ;
Akbulut, Hakan .
BRAIN RESEARCH, 2008, 1238 :31-35
[2]   Melatonin decreases apoptosis in gastric mucosa during aging [J].
Akbulut, K. Gonca ;
Akbulut, Hakan ;
Akgun, Nalan ;
Gonul, Bilge .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 24 (01) :15-20
[3]   Study of the nitric oxide system in the rat cerebellum during aging [J].
Blanco, Santos ;
Molina, Francisco J. ;
Castro, Lourdes ;
Del Moral, Maria L. ;
Hernandez, Raquel ;
Jimenez, Ana ;
Rus, Alma ;
Martinez-Lara, Esther ;
Siles, Eva ;
Peinado, Maria A. .
BMC NEUROSCIENCE, 2010, 11
[4]   Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death [J].
CasciolaRosen, L ;
Nicholson, DW ;
Chong, T ;
Rowan, KR ;
Thornberry, NA ;
Miller, DK ;
Rosen, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :1957-1964
[5]   Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells [J].
Chetsawang, Jirapa ;
Govitrapong, Piyarat ;
Chetsawang, Banthit .
JOURNAL OF PINEAL RESEARCH, 2007, 43 (02) :115-120
[6]   Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress [J].
Das, Arabinda ;
Belagodu, Amogh ;
Reiter, Russel J. ;
Ray, Swapan K. ;
Banik, Naren L. .
JOURNAL OF PINEAL RESEARCH, 2008, 45 (02) :117-124
[7]   Cytokine-induced activation of glial cells in the mouse brain is enhanced at an advanced age [J].
Deng, X. -H. ;
Bertini, G. ;
Xu, Y. Z. ;
Yan, Z. ;
Bentivoglio, M. .
NEUROSCIENCE, 2006, 141 (02) :645-661
[8]   Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases [J].
Floyd, RA ;
Hensley, K .
NEUROBIOLOGY OF AGING, 2002, 23 (05) :795-807
[9]   Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases [J].
Friedlander, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1365-1375
[10]   Age and Neuroinflammation: A Lifetime of Psychoneuroimmune Consequences [J].
Godbout, Jonathan P. ;
Johnson, Rodney W. .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2009, 29 (02) :321-+